ITRADE works with STEM organizations to close Technology, Talent, & Security gaps. See how →
The ITRADE Dispatch is an educational resource — not medical advice. Consult a qualified healthcare provider before starting any new supplement or health protocol.
| The Lead |
The biohacking industry crossed $20 billion globally in 2025 and is projected to reach $56 billion by 2034. The fastest-growing segments — wearables, metabolic monitoring, and longevity interventions — are pulling in corporate wellness budgets alongside individual consumers. Nine out of ten corporate wellness programs now include digital tracking components. Oura reported revenues exceeding $500 million in 2024 and projected $1 billion for 2025.
Two modalities sit at the center of this movement: cold-water immersion and red light therapy. Both have massive consumer adoption, growing clinical interest, and evidence profiles worth understanding in detail. For STEM leaders responsible for workforce health, facility investments, or their own optimization stack, the distinction between a plausible mechanism and a proven outcome is the whole game.
What cold exposure does
The largest systematic review to date — 11 studies, 3,177 participants, published in PLOS One in January 2025 — examined cold-water immersion's health effects in the general population.
Cold-water immersion produced a significant reduction in stress — measured at 12 hours post-exposure. It showed improvements in sleep quality and quality of life. A 29% reduction in sickness absence was reported among participants who took cold showers for at least 30 seconds daily. Insulin sensitivity improved in multiple studies of regular winter swimmers.
The review also found that cold-water immersion increased inflammation immediately after and one hour post-exposure. No significant effects on immunity were detected at any time point. No significant effects on mood. The overall certainty of evidence was graded D — inconsistent or inconclusive studies across all levels.
A 2024 review in the Journal of Thermal Biology found cold exposure enhanced parasympathetic nervous system activity, measured through heart rate variability (HRV). Harvard sports cardiologist Dr. Prashant Rao noted that HRV improvements "have not consistently shown any connection with better cardiovascular outcomes."
The cold shock response — the gasp, heart rate spike, blood pressure surge — carries real risk. People with heart rhythm disorders, peripheral artery disease, or Raynaud's syndrome should avoid it entirely. Professor Mike Tipton, a leading researcher: "Sitting in water for as long as I can fills me with horror. This could destroy small nerves, blood vessels in extremities."
The evidence summary: cold exposure has real physiological effects. Stress reduction, improved insulin sensitivity, and reduced sickness absence are promising findings. The evidence base remains limited by few RCTs, small sample sizes, and narrow study populations. Benefits are time-dependent and the risks are real.
What red light therapy does
Red light therapy — formally photobiomodulation (PBM) — has a longer research history than most realize. The mechanism is well-characterized: specific wavelengths of red (630-660 nm) and near-infrared (830-850 nm) light are absorbed by mitochondrial chromophores, enhancing ATP production, activating transcription factors, and producing downstream cellular effects.
In 2025, a 21-member expert panel published an evidence-based consensus in the Journal of the American Academy of Dermatology: PBM is safe for adult patients, does not induce DNA damage, and is an effective treatment for peripheral neuropathy, androgenetic alopecia, wound ulcers, and acute radiation dermatitis.
Stanford Medicine's assessment aligned directionally: "There's real evidence that shows red light can change biology." Hair growth and skin rejuvenation have "fairly robust evidence." Wound healing has preliminary data. Athletic performance and sleep lack supporting evidence at this stage.
The emerging frontier is neurological. A randomized, placebo-controlled trial in 93 older adults with mild cognitive impairment showed significant cognitive improvement after 60 days of transcranial near-infrared PBM, with elevated BDNF levels persisting at three-month follow-up. Fibromyalgia trials showed large, durable pain reductions through six months.
The structural challenge: non-standardized dosimetry, inconsistent energy delivery, and heterogeneous study endpoints across trials. Home-use devices operate with even less standardization. "It all depends on the strength and duration of the treatment," as Stanford dermatologist Dr. Zakia Rahman put it.
The framework: Instrument, Integrate, Intervene
Instrument: Establish baselines before adding any modality. HRV, sleep architecture, inflammatory markers, metabolic panels. Without a baseline, you cannot distinguish a real effect from placebo or regression to the mean.
Integrate: No single modality works in isolation. Cold exposure added to a sleep-deprived, under-recovered system is an additional stressor. Red light therapy without appropriate dosimetry for your specific condition is expensive ambient lighting.
Intervene: Choose modalities where the evidence matches your specific goal. Cold exposure for stress management and metabolic conditioning — supported. Red light for hair restoration or skin rejuvenation in clinical settings — supported. Red light for athletic performance or sleep — insufficient evidence. Cold exposure for immunity — insufficient evidence.
The $22 billion biohacking market will continue to grow. The leaders who benefit most will treat their biology the same way they treat their infrastructure: data-first, evidence-informed, and skeptical of vendor claims that outrun the research.
The leaders who benefit most will treat their biology the same way they treat their infrastructure: data-first, evidence-informed, and skeptical of vendor claims that outrun the research.
| Signals · This Week in STEM |
Bianca architects the systems most leaders buy in pieces - talent, technology, and security, designed to work as one.